We're experiencing a higher volume of calls and emails than usual and will get back to you as soon as we can. We appreciate your patience.
For the latest advice on COVID-19, please visit our dedicated information hub.

Elotuzumab Horizons Infosheet

This Horizons Infosheet contains information about elotuzumab (Empliciti®), a drug being investigated for the treatment of myeloma.

Last updated: November 2019
Review date: May 2020